Coya Therapeutics, Inc./$COYA
1D1W1MYTD1Y5YMAX
Capital at risk
About Coya Therapeutics, Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (Tregs). The company's initial development programs are focused on neurodegenerative, chronic inflammatory, autoimmune, and metabolic diseases with high unmet medical needs.
- Ticker
- $COYA
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 8
- Headquarters
- Houston, United States
- Website
- www.coyatherapeutics.com
COYA Metrics
BasicAdvanced
$109M
-
-$1.09
0.62
-
Price and volume
Market cap
$109M
Beta
0.62
52-week high
$7.75
52-week low
$3.71
Average daily volume
115K
Financial strength
Current ratio
13.397
Quick ratio
12.294
Profitability
EBITDA (TTM)
-20.83
Gross margin (TTM)
-111.80%
Net profit margin (TTM)
-270.22%
Operating margin (TTM)
-260.00%
Effective tax rate (TTM)
-0.01%
Revenue per employee (TTM)
$1,000,000
Management effectiveness
Return on assets (TTM)
-32.27%
Return on equity (TTM)
-60.54%
Valuation
Price to revenue (TTM)
11.537
Price to book
2.52
Price to tangible book (TTM)
2.52
Price to free cash flow (TTM)
-5.205
Free cash flow yield (TTM)
-19.21%
Free cash flow per share (TTM)
-0.893
Growth
Revenue change (TTM)
1,793.76%
Earnings per share change (TTM)
-12.94%
3-year earnings per share growth (CAGR)
-19.48%
Upcoming events
No upcoming events
COYA News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.